ArticleLe Mali medical2025
[Chronic Kidney Disease Stages 3-5 In Women Of Childbearing Age At Tanguiéta Hospital (Benin)].
Article in Le Mali medical, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To study the epidemiological, clinical and evolutionary aspects of chronic kidney disease (CKD) stages 3-5 in women of childbearing age at Saint Jean de Dieu Hospital in Tanguiéta from 2018-2021. Methods: This was a longitudinal study, with data collection from 1 January 2018 to 31 August 2021. All women of childbearing age with a diagnosis of stage 3-5 CKD and who had given their consent were included. The dependent variable was CKD progression. Progression was considered unfavourable after 3 months of follow-up in patients with a GFR <15ml/mn/1.73m2. The significance threshold was p<0.05. Results: Of 7865 women of childbearing age admitted to the hospital, 70 had CKD stages 3-5, representing a hospital frequency of 0.9%. The mean age of the patients was 45±11 years. During the 3 months of follow-up, 26 deaths (37.1%) were recorded. Of the remaining 44 patients, 37 (84.1%) had persistent stage 5 CKD. Self-medication (p=.0232), use of oestroprogestins (p=0.0289) and hypokalaemia (p=0.0043) were significantly associated with an unfavourable outcome. Conclusion: The majority of CKD stages 3-5 in women of childbearing age were unfavourable. Rigorous and early management is needed to improve renal health as much as possible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.